z-logo
Premium
Group III metabotropic glutamate receptors and D 1 ‐like and D 2 ‐like dopamine receptors interact in the rat nucleus accumbens to influence locomotor activity
Author(s) -
David Hélène N.,
Abraini Jacques H.
Publication year - 2002
Publication title -
european journal of neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.346
H-Index - 206
eISSN - 1460-9568
pISSN - 0953-816X
DOI - 10.1046/j.1460-9568.2002.01919.x
Subject(s) - quinpirole , metabotropic glutamate receptor , agonist , metabotropic receptor , dopamine receptor d2 , nucleus accumbens , pharmacology , receptor , metabotropic glutamate receptor 1 , chemistry , long term depression , glutamate receptor , dopamine , neuroscience , biology , ampa receptor , biochemistry
Evidence for functional interactions between metabotropic glutamate (mGlu) receptors and dopamine (DA) neurotransmission is now clearly established. In the present study, we investigated interactions between group III mGlu receptors and D 1 ‐ and D 2 ‐like receptors in the nucleus accumbens (NAcc). Administration, into the NAcc, of the selective group III mGlu receptor agonist, AP4, resulted in an increase in locomotor activity, which was blocked by pretreatment with the group III mGlu receptor antagonist, MPPG. In addition, pretreatment with AP4 further blocked the increase in motor activity induced by the D 1 ‐like receptor agonist, SKF 38393, but potentiated the locomotor responses induced by either the D 2 ‐like receptor agonist, quinpirole, or coinfusion of SKF 38393 and quinpirole. MPPG reversed the effects of AP4 on the motor responses induced by D 1 ‐like and/or D 2 ‐like receptor activation. These results confirm that glutamate transmission may control DA‐dependent locomotor function through mGlu receptors and further indicate that group III mGlu receptors oppose the behavioural response produced by D 1 ‐like receptor activation and favour those produced by D 2 ‐like receptor activation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here